Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nobuki Kitagawa is active.

Publication


Featured researches published by Nobuki Kitagawa.


Psychiatry Research-neuroimaging | 2001

Abnormal neuronal network in anorexia nervosa studied with I-123-IMP SPECT.

Akihiro Takano; Tohru Shiga; Nobuki Kitagawa; Tsukasa Koyama; Chietsugu Katoh; Eriko Tsukamoto; Nagara Tamaki

Single photon emission computed tomography was used to study 14 female patients with anorexia nervosa and 8 female normal comparison subjects. Automatic voxel-based analysis of the images was carried out using statistical parametric mapping (SPM) software. Statistics across the entire brain were displayed as Z scores (threshold: P<0.05). Compared with the normal comparison subjects, the anorectic patients were characterized by hypoperfusion in the medial prefrontal cortex and the anterior cingulate gyrus, and hyperperfusion in the thalamus and the amygdala-hippocampus complex. These results suggest that a dysfunction in neuronal circuitry may be related to anorexia nervosa.


Journal of Affective Disorders | 2000

Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depression

Takeshi Izumi; Takeshi Inoue; Nobuki Kitagawa; Nobuyuki Nishi; Shoji Shimanaka; Yoshito Takahashi; Ichiro Kusumi; Yuji Odagaki; Kenzo Denda; T. Ohmori; Tsukasa Koyama

Background: Recently, a dopamine hypothesis of depression was put forward, and several studies have demonstrated that direct and indirect dopamine agonists have antidepressant effects. Methods: Using Clinical Global Impressions, we evaluated the efficacy of 4-week treatment of pergolide as an antidepressant adjuvant involving 20 unipolar depressed patients who were refractory to standard treatment with antidepressants. Results: One patients (5%) were very much improved, seven (35%) much improved, four (20%) minimally improved, six (30%) no change or worse, and two (10%) not assessed. There was no significant difference in any clinical factors between the pergolide responder and non-responder group. Limitations: This study was a non-blind open trial, and pergolide was added to tricyclic and heterocyclic antidepressants. Conclusion: Pergolide may be useful as an antidepressant adjuvant, suggesting a potential role for dopamine-2 stimulation in the antidepressant response.


Psychiatry Research-neuroimaging | 2013

Impaired integrity of the brain parenchyma in non-geriatric patients with major depressive disorder revealed by diffusion tensor imaging

Khin Khin Tha; Satoshi Terae; Shin Nakagawa; Takeshi Inoue; Nobuki Kitagawa; Yuki Kako; Yasuya Nakato; Kawser Akter Popy; Noriyuki Fujima; Yuri Zaitsu; Daisuke Yoshida; Yoichi M. Ito; Tamaki Miyamoto; Tsukasa Koyama; Hiroki Shirato

Diffusion tensor imaging (DTI) is considered to be able to non-invasively quantify white matter integrity. This study aimed to use DTI to evaluate white matter integrity in non-geriatric patients with major depressive disorder (MDD) who were free of antidepressant medication. DTI was performed on 19 non-geriatric patients with MDD, free of antidepressant medication, and 19 age-matched healthy subjects. Voxel-based and histogram analyses were used to compare fractional anisotropy (FA) and mean diffusivity (MD) values between the two groups, using two-sample t tests. The abnormal DTI indices, if any, were tested for correlation with disease duration and severity, using Pearson product-moment correlation analysis. Voxel-based analysis showed clusters with FA decrease at the bilateral frontal white matter, anterior limbs of internal capsule, cerebellum, left putamen and right thalamus of the patients. Histogram analysis revealed lower peak position of FA histograms in the patients. FA values of the abnormal clusters and peak positions of FA histograms of the patients exhibited moderate correlation with disease duration and severity. These results suggest the implication of frontal-subcortical circuits and cerebellum in MDD, and the potential utility of FA in evaluation of brain parenchymal integrity.


Neuropsychiatric Disease and Treatment | 2014

The association between suicide risk and self-esteem in Japanese university students with major depressive episodes of major depressive disorder.

Nobuyuki Mitsui; Satoshi Asakura; Yusuke Shimizu; Yutaka Fujii; Atsuhito Toyomaki; Yuki Kako; Teruaki Tanaka; Nobuki Kitagawa; Takeshi Inoue; Ichiro Kusumi

Background The suicide risk among young adults is related to multiple factors; therefore, it is difficult to predict and prevent suicidal behavior. Aim We conducted the present study to reveal the most important factors relating to suicidal ideation in Japanese university students with major depressive episodes (MDEs) of major depressive disorder (MDD). Methods The subjects were 30 Japanese university students who had MDEs of MDD, and were aged between 18 and 26 years old. They were divided into two groups – without suicide risk group (n=15), and with suicide risk group (n=15) – based on the results of the Mini-International Neuropsychiatric Interview. Additionally, healthy controls were recruited from the same population (n=15). All subjects completed the self-assessment scales including the Beck Depression Inventory 2nd edition (BDI-II), the Beck Hopelessness Scale (BHS), Rosenberg’s Self-Esteem Scale (RSES), and SF-36v2™ (The Medical Outcomes Study 36-item short-form health survey version 2), and they were all administered a battery of neuropsychological tests. Results The RSES score of the suicide risk group was significantly lower than the RSES score of the without suicide risk group, whereas the BDI-II score and the BHS score were not significantly different between the two groups. The mean social functioning score on the SF-36v2 of the with suicide risk group was significantly lower than that of the without suicide risk group. Conclusion The individual’s self-esteem and social functioning may play an important role in suicide risk among young adults with MDEs of MDD.


JMIR mental health | 2018

Cognitive and Behavioral Skills Exercises Completed by Patients with Major Depression During Smartphone Cognitive Behavioral Therapy: Secondary Analysis of a Randomized Controlled Trial

Toshi A. Furukawa; Masaru Horikoshi; Hirokazu Fujita; Naohisa Tsujino; Ran Jinnin; Yuki Kako; Sei Ogawa; Hirotoshi Sato; Nobuki Kitagawa; Yoshihiro Shinagawa; Yoshio Ikeda; Hissei Imai; Aran Tajika; Yusuke Ogawa; Tatsuo Akechi; Mitsuhiko Yamada; Shinji Shimodera; Norio Watanabe; Masatoshi Inagaki; Akio Hasegawa

Background A strong and growing body of evidence has demonstrated the effectiveness of cognitive behavioral therapy (CBT), either face-to-face, in person, or as self-help via the Internet, for depression. However, CBT is a complex intervention consisting of several putatively effective components, and how each component may or may not contribute to the overall effectiveness of CBT is poorly understood. Objective The aim of this study was to investigate how the users of smartphone CBT use and benefit from various components of the program. Methods This is a secondary analysis from a 9-week, single-blind, randomized controlled trial that has demonstrated the effectiveness of adjunctive use of smartphone CBT (Kokoro-App) over antidepressant pharmacotherapy alone among patients with drug-resistant major depressive disorder (total n=164, standardized mean difference in depression severity at week 9=0.40, J Med Internet Res). Kokoro-App consists of three cognitive behavioral skills of self-monitoring, behavioral activation, and cognitive restructuring, with corresponding worksheets to fill in. All activities of the participants learning each session of the program and completing each worksheet were uploaded onto Kokoro-Web, which each patient could use for self-check. We examined what use characteristics differentiated the more successful users of the CBT app from the less successful ones, split at the median of change in depression severity. Results A total of 81 patients with major depression were allocated to the smartphone CBT. On average, they completed 7.0 (standard deviation [SD] 1.4) out of 8 sessions of the program; it took them 10.8 (SD 4.2) days to complete one session, during which they spent 62 min (SD 96) on the app. There were no statistically significant differences in the number of sessions completed, time spent for the program, or the number of completed self-monitoring worksheets between the beneficiaries and the nonbeneficiaries. However, the former completed more behavioral activation tasks, engaged in different types of activities, and also filled in more cognitive restructuring worksheets than the latter. Activities such as “test-drive a new car,” “go to a coffee shop after lunch,” or “call up an old friend” were found to be particularly rewarding. All cognitive restructuring strategies were found to significantly decrease the distress level, with “What would be your advice to a friend who has a similar problem?” found more helpful than some other strategies. Conclusions The CBT program offered via smartphone and connected to the remote server is not only effective in alleviating depression but also opens a new avenue in gathering information of what and how each participant may utilize the program. The activities and strategies found useful in this analysis will provide valuable information in brush-ups of the program itself and of mobile health (mHealth) in general. Trial Registration Japanese Clinical Trials Registry UMIN CTR 000013693; https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ ctr_view.cgi?recptno=R000015984 (Archived by WebCite at http://www.webcitation.org/6u6pxVwik)


Asia-pacific Psychiatry | 2010

“Rework Program” in Japan: Innovative high-level rehabilitation

Tsuyoshi Akiyama; Masao Tsuchiya; Yoshio Igarashi; Norio Ozaki; Motonori Yokoyama; Yoko Katagiri; Miyuki Tajima; Miki Matsunaga; Nobuki Kitagawa; Haruo Nakamoto; Peter J Bernick

Introduction: The aim of this paper is to report on the Rework Program, a type of high‐level rehabilitation program developed in Japan, and on Cognitive‐Behavioral Group Therapy for Rework (CBGTR), which was also developed in Japan.


Neuropsychiatric Disease and Treatment | 2013

Differences between bipolar and unipolar depression on Rorschach testing

Hiromi Kimura; Akemi Osaki; Rui Kawashima; Takeshi Inoue; Shin Nakagawa; Katsuji Suzuki; Satoshi Asakura; Teruaki Tanaka; Yuji Kitaichi; Takuya Masui; Nobuki Kitagawa; Yuki Kako; Tomohiro Abekawa; Ichiro Kusumi; Hiroyoshi Yamanaka; Kenzo Denda; Tsukasa Koyama

Background The bipolar-unipolar distinction in patients with a major depressive episode is the most important issue related to the diagnosis and treatment of mood disorders, but remains unresolved. This study was undertaken to compare bipolar and unipolar depression on Rorschach testing using the Comprehensive System with reference to healthy Japanese controls. Methods Patients with bipolar or unipolar depression who had undergone the Rorschach test for routine clinical purposes were followed up naturalistically for a long period. Based on diagnostic confirmation after long-term follow-up, scores on this test for patients with bipolar and unipolar depression were compared with those published elsewhere for healthy Japanese controls. Results The bipolar depression group showed significantly higher scores or positive findings in five variables of the Rorschach test, ie, WSum6, DR2 > 0, (CF + C) > FC + 2, PureC > 1, and Populars > 7, as assessed using the Comprehensive System, than did the unipolar depression group and healthy controls. These scores did not differ between the unipolar depression and control groups. Conclusion The results of this study show thought disorder or cognitive slippage and marked laxness in modulating emotion in bipolar depression, indicating the psychopathological characteristics of bipolar disorder.


Seishin Igaku (Clinical Psychiatry) | 2002

Reliability and validity of the Japanese version of the Liebowitz Social Anxiety Scale.

Satoshi Asakura; Seishiro Inoue; Fumi Sasaki; Yukiya Sasaki; Nobuki Kitagawa; Takeshi Inoue; Kenzo Denda; Tsukasa Koyama; Masumi Ito; Ryoji Matsubara


Psychiatry Research-neuroimaging | 2007

A case of anorexia nervosa with Marchiafava-Bignami Disease that responded to high-dose intravenous corticosteroid administration

Hiroki Tao; Nobuki Kitagawa; Yuki Kako; Hiroyoshi Yamanaka; Koichi Ito; Kenzo Denda; Tsukasa Koyama


Japanese journal of child and adolescent psychiatry. | 2004

DEPRESSIVE SYMPTOMS IN A SCHOOL SAMPLE OF CHILDREN AND ADOLESCENTS ; USING THE BIRLESON DEPRESSION SELF-RATING SCALE FOR CHILDREN (DSRS-C)

Kenzo Denda; Yuki Kako; Yukiya Sasaki; Koichi Ito; Nobuki Kitagawa; Tsukasa Koyama

Collaboration


Dive into the Nobuki Kitagawa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge